Advanced search
Publication Cover
mAbs Volume 12, 2020 - Issue 1
Submit an article Journal homepage
3,132
Views
20
CrossRef citations to date
0
Altmetric
Report

Dose escalation PET imaging for safety and effective therapy dose optimization of a bispecific antibody

Yan Wanga Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, China;b Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, ChinaView further author information
,
Donghui Panc NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, ChinaView further author information
,
Chenrong Huanga Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, China;b Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, ChinaView further author information
,
Bingliang Chend Drug Discovery Department, Innovent Biopharmaceutical (Suzhou) Co., Ltd, Suzhou, ChinaView further author information
,
Mingzhu Lic NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, ChinaView further author information
,
Shuaixiang Zhoud Drug Discovery Department, Innovent Biopharmaceutical (Suzhou) Co., Ltd, Suzhou, ChinaView further author information
,
Lizhen Wangc NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, ChinaView further author information
,
Min Wud Drug Discovery Department, Innovent Biopharmaceutical (Suzhou) Co., Ltd, Suzhou, ChinaView further author information
,
Xinyu Wangc NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, ChinaView further author information
,
Yicong Biana Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, China;b Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, ChinaView further author information
,
Junjie Yanc NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, ChinaView further author information
,
Junjian Liud Drug Discovery Department, Innovent Biopharmaceutical (Suzhou) Co., Ltd, Suzhou, ChinaView further author information
,
Min Yangc NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu, ChinaCorrespondence[email protected]
View further author information
&
Liyan Miaoa Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, China;b Institute for Interdisciplinary Drug Research and Translational Sciences, College of Pharmaceutical Sciences, Soochow University, Suzhou, ChinaCorrespondence[email protected]
View further author information
 show all
Article: 1748322 | Received 06 Jan 2020, Accepted 24 Mar 2020, Published online: 10 Apr 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.